iVS-1® is an ecologically-advanced® probiotic, Bifidobacterium adolescentis iVS-1®. It was discovered by our leading scientific experts, with four published papers on the strain from inception to clinical trial (Krumbeck et al., 2018).

In humans, iVS-1® is demonstrated to:

  • Clinically shown to support gut barrier integrity, which impacts important aspects of the immune system and the body’s metabolism
  • Reached a 10x higher level in the gut than a leading strain of Bifidobacterium in a randomized, double-blind, placebo-controlled clinical trial
  • Persists longer in the gut
  • Helps maintain and support a healthy immune system
  • Supports digestive health
  • May support healthy metabolic function
  • Clinically demonstrated to increase the total amount of bifidobacteria in the human gut. Bifidobacterium levels have been shown to decrease as we age
  • Supports a tight gut lining
  • Helps balance the microbiome
  • iVS-1® has been clinically paired with the targeted prebiotic GOS, which it competitively consumes
  • Native to the human gut
  • Effective clinical doses as low as 1 Billion CFU per day

Synbiotic Health offers B. adolescentis iVS-1® as a bulk powder or in finished product formulation. B. adolescentis iVS-1® is effective at doses as low as 1 Billion CFU per day. Optionally, the strain may be combined with a partner prebiotic, galactooligosaccharide (GOS), to create a ‘complementary synbiotic’ ingredient.

iVS-1® is suitable for delivery in various dietary supplement product forms, and in select food product types.